Seller record · Telehealth service

Push Health

By Peptide Alliance, Editorial publisherRecorded October 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: The platform sends prescriptions to the patient’s preferred pharmacy or manufacturer program rather than identifying a dispensing pharmacy in its weight-loss offer. 2 more criteria also fail; see the table below.

At a glance

Push HealthTelehealth service

4/8criteria passed

Price: Not printed before a consultation or sign-up
Sells: Wegovy, Ozempic, Zepbound, and 2 more
FDA letters: None on file

Visit Push Health See all eight dispositions

Telehealth service. Passes 4 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A telehealth platform connecting patients with licensed prescribers for weight-loss medication, with prescriptions sent to the patient’s chosen pharmacy or manufacturer program.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Push Health's weight loss page
S2	Prescription gating	PASS	Push Health's weight loss page
S3	Pharmacy identification	FAIL	Push Health's weight loss page; Push Health's for patient page
S4	Compounding disclosure	PASS	Push Health's weight loss page; Push Health's GLP-1 page
S5	Analytical documentation	FAIL	Push Health's weight loss page; Push Health's GLP-1 page
S6	Business address	NOT VERIFIED	Push Health's about page
S7	Price disclosure	FAIL	Push Health's weight loss page; Push Health's Zepbound page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSThe weight-loss service describes a licensed medical provider reviewing patient information and prescribing only when appropriate.Source: Push Health's weight loss page.

S2PASSThe public service sequence places provider review and evaluation before a prescription is sent to a pharmacy or manufacturer program chosen by the patient.Source: Push Health's weight loss page.

S3FAILThe platform sends prescriptions to the patient’s preferred pharmacy or manufacturer program rather than identifying a dispensing pharmacy in its weight-loss offer.Source: Push Health's weight loss page; Push Health's for patient page.

S4PASSThe weight-loss and GLP-1 pages describe branded prescription products by name, including Wegovy, Ozempic, Zepbound and Mounjaro, without offering a compounded version on those pages.Source: Push Health's weight loss page; Push Health's GLP-1 page.

S5FAILThe weight-loss and GLP-1 service pages publish no certificate of analysis or equivalent lot document.Source: Push Health's weight loss page; Push Health's GLP-1 page.

S6NOT VERIFIEDThe business-address question did not resolve from the published material. The company page identifies El Segundo, California but does not print a street address. The linked legal PDF was not available to establish a full business address. The check is open.Source: Push Health's about page.

S7FAILNo platform medication price is printed on the weight-loss service page. The Zepbound page’s typical starting cost describes manufacturer or retail-pharmacy pricing, not a Push Health medication offer.Source: Push Health's weight loss page; Push Health's Zepbound page.

S8PASSNo FDA warning letter names Push Health or its named co-founder Chirag Shah, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: Wegovy, Ozempic, Zepbound, Mounjaro, Foundayo.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit Push Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.